 |
市场调查报告书
商品编码
1550536
製药业人工智慧 (AI) 的全球市场：按部署模式、按交付、按技术、按药物类型、按应用、按最终用户、按地区Global Artificial Intelligence In Pharmaceutical Market, By Deployment Mode, By Offering, By Technology, By Drug Type, By Application, By End User, By Geography |
||||||
价格
简介目录
预计2024年全球人工智慧（AI）在药品领域的市场规模为11.081亿美元，2024年至2031年复合年增长率为32.1%，2031年将达到77.762亿美元。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 11.081 亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024-2031 |
| 预测 2024-2031 年复合年增长率： | 32.10% | 2031年价值预测 | 77.762 亿美元 |
图：2024 年按地区分類的人工智慧 (AI)全球市场占有率(%)
人工智慧 (AI) 已成为一项变革性技术，将彻底改变製药业。透过利用大量资料和先进演算法，人工智慧有潜力帮助药品製造商加速药物发现、简化临床试验并实现更准确的诊断和治疗。人工智慧透过快速分析大量资料集并识别可能导致新治疗方法的关係，有力地支持了药物科学家的工作。利用人工智慧，研究人员可以以前所未有的规模和速度分析基因序列资讯和电子健康记录。这项技术可以帮助发现新的治疗方法并预测重新利用现有药物治疗其他疾病的潜力。人工智慧可望增强人类能力，提高药物研发效率，更快为病患带来创新药物。
市场动态：
降低药物发现和开发成本、缩短药物开发週期和推动精准医疗的需求日益增长，推动了全球製药业人工智慧 (AI) 市场的成长。人工智慧可以加速药物发现，减少昂贵的后期临床试验的失败，并帮助药物更快推向市场。然而，人工智慧模型缺乏可解释性以及对其融入决策的怀疑可能会阻碍其采用。增加药物资料集的可用性和加强法律规范可以提供重大的成长机会。如果处理得当，可以克服可解释性问题和缺乏专业知识，并实现这种变革性技术的全部潜力。
本研究的主要特点
- 这份报告对全球製药人工智慧（AI）市场进行了详细分析，并提供了我以2023年为基准年的预测期（2024-2031年）的市场规模和年复合成长率（CAGR%）。 。
- 它阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
- 它根据公司亮点、产品系列、主要亮点、财务业绩和策略等参数，介绍了全球製药市场人工智慧 (AI)的主要企业。
- 该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
- 全球製药市场人工智慧 (AI) 报告迎合了该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
- 相关人员可以透过分析全球製药人工智慧 (AI) 市场时使用的各种策略矩阵来促进决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章 市场动态、法规与趋势分析
- 市场动态
- 促进因素
- 抑制因素
- 机会
- 影响分析
- 市场趋势
- 主要进展
- 监管场景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
第 4 章：全球製药人工智慧 (AI) 市场 - 新型冠状病毒 (COVID-19) 大流行的影响
- 整体影响
- 政府倡议
- COVID-19 对市场的影响
第五章全球製药人工智慧（AI）市场：按部署类型（2019-2031）
- 云
- 本地
第六章 全球製药人工智慧 (AI) 市场：依产品分类（2019-2031）
- 硬体
- 软体
- 服务
第七章 全球製药人工智慧 (AI) 市场：依技术分类（2019-2031）
- 自然语言处理
- 情境感知处理
- 深度学习
- 查询研究方法
- 其他的
第八章全球医药人工智慧（AI）市场：依药品类型分类（2019-2031）
- 高分子
- 小分子
第九章全球医药人工智慧（AI）市场：依应用分类（2019-2031）
- 药物发现
- 临床试验
- 研究与开发
- 药品製造及供应链
- 其他的
第10章全球製药人工智慧（AI）市场：依最终用户分类（2019-2031）
- 製药和生物技术公司
- 医院和诊断中心
- 学术研究所
- 其他的
第十一章全球製药人工智慧（AI）市场：按地区（2019-2031）
- 拉丁美洲
- 欧洲
- 亚太地区
- 中国
- 印度
- 日本
- ASEAN
- 澳洲
- 韩国
- 其他亚太地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中部非洲
- 南非
第十二章竞争格局
- 公司简介
- NVIDIA Corporation
- IBM Corporation
- Exscientia
- Insilico Medicine
- Atomwise, Inc.
- Cloud Pharmaceuticals, Inc.
- Cyclica Inc.
- Envisagenics, Inc.
- Numerate, Inc.
- Schrodinger, Inc.
- Standigm
- Turbine.ai
- BenevolentAI
- Recursion Pharmaceuticals
- Owkin, Inc.
- XtalPi Inc.
- Valo Health
- Absci
第十三章分析师建议
- Wheel of Fortune
- 分析师观点
- Coherent Opportunity Map（COM）
第十四章参考文献与调查方法
- 参考
- 调查方法
简介目录
Product Code: CMI7209
Global artificial intelligence (AI) in pharmaceutical market is estimated to be valued at USD 1,108.1 Mn in 2024 and is expected to reach USD 7,776.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 32.1% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 1,108.1 Mn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 32.10% | 2031 Value Projection: | US$ 7,776.2 Mn |
Figure. Global Artificial Intelligence (AI) In Pharmaceutical Market Share (%), By Region 2024
Artificial intelligence (AI) has emerged as a transformative technology that is poised to revolutionize the pharmaceutical industry. By leveraging huge amounts of data and sophisticated algorithms, AI has the potential to help drug makers to accelerate drug discovery, streamline clinical trials and enable more precise diagnosis and treatment. AI augments the work of pharmaceutical scientists by swiftly analyzing huge datasets to identify relationships that may lead to new therapies. With AI, researchers can analyze genetic sequencing information or electronic health records at an unprecedented scale and speed. The technology helps discover new therapies and predict which existing drugs could be repurposed to treat other conditions. AI promises to augment human capabilities, make pharmaceutical R&D more efficient and bring innovative new medicines to patients faster.
Market Dynamics:
Global artificial intelligence (AI) in pharmaceutical market growth is driven by rising need to control drug discovery and development costs, reduce the drug development cycle time and advance precision medicine. AI can accelerate drug discovery, reduce expensive late-stage clinical trial failures and help launch drugs faster. However, lack of interpretability of AI models and skepticism about integrating it into decision-making can hamper its adoption. Growing availability of pharma data sets and encouraging regulatory frameworks can offer significant growth opportunities. If addressed properly, interpretability issues and lack of expertise can be overcome to extract full potential from this transformative technology.
Key Features of the Study:
- This report provides in-depth analysis of the global artificial intelligence (AI) in pharmaceutical market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global artificial intelligence (AI) in pharmaceutical market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include IBM, Microsoft, AWS, Google, Anthropic, Berg Health and InSilico Medicine
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global artificial intelligence (AI) in pharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence (AI) in pharmaceutical market
Detailed Segmentation-
- By Deployment Mode
- Cloud
- On-Premise
- By Offering
- Hardware
- Software
- Services
- By Technology
- Natural Language Processing
- Context-Aware Processing
- Deep Learning
- Querying Method
- Other
- By Drug Type
- Large Molecules
- Small Molecules
- By Application
- Drug Discovery
- Clinical Trial
- Research & Development
- Drug Manufacturing and Supply Chain
- Others
- By End User
- Pharmaceutical & Biotechnology Companies
- Hospitals and Diagnostic Centers
- Academic & Research Institutes
- Others
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- NVIDIA Corporation
- IBM Corporation
- Exscientia
- Insilico Medicine
- Atomwise, Inc.
- Cloud Pharmaceuticals, Inc.
- Cyclica Inc.
- Envisagenics, Inc.
- Numerate, Inc.
- Schrodinger, Inc.
- Standigm
- BenevolentAI
- Recursion Pharmaceuticals
- Owkin, Inc.
- XtalPi Inc.
- Valo Health
- Absci
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Deployment Mode
- Market Snapshot, By Offering
- Market Snapshot, By Technology
- Market Snapshot, By Drug Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Artificial Intelligence (AI) in Pharmaceutical Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Deployment Mode, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Cloud
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- On-Premise
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Offering, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Hardware
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Software
- Mammography
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Services
- Chest X-ray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
7. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Technology, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Natural Language Processing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Context-Aware Processing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Deep Learning
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Querying Method
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
8. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Drug Type, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Large Molecules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Small Molecules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
9. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Application, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Drug Discovery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Clinical Trial
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Research & Development
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Drug Manufacturing and Supply Chain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
10. Global Artificial Intelligence (AI) in Pharmaceutical Market, By End User, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Pharmaceutical & Biotechnology Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Hospitals and Diagnostic Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
11. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Region, 2019 - 2031, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
12. Competitive Landscape
- Company Profiles
- NVIDIA Corporation
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- IBM Corporation
- Exscientia
- Insilico Medicine
- Atomwise, Inc.
- Cloud Pharmaceuticals, Inc.
- Cyclica Inc.
- Envisagenics, Inc.
- Numerate, Inc.
- Schrodinger, Inc.
- Standigm
- Turbine.ai
- BenevolentAI
- Recursion Pharmaceuticals
- Owkin, Inc.
- XtalPi Inc.
- Valo Health
- Absci
- NVIDIA Corporation
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
